Indication

CTLA4 haploinsufficiency

1 clinical trial

1 product

Clinical trial

A Phase 1 Study to Evaluate IMM27M Safety, Tolerability, Pharmacokinetics and Anti-tumor Activity in Patients With Advanced, Metastatic Solid Tumor

Status: Recruiting, Estimated PCD: 2023-08-30

Product